PCRX Lawsuit Alert! Class Action Lawsuit Against Pacira Biosciences, Inc.
PremiumMarket NewsPCRX Lawsuit Alert! Class Action Lawsuit Against Pacira Biosciences, Inc.
1M ago
Pacira BioSciences Reports Record Revenues and Strategic Growth
Premium
Company Announcements
Pacira BioSciences Reports Record Revenues and Strategic Growth
1M ago
Pacira price target raised to $24 from $17 at Barclays
Premium
The Fly
Pacira price target raised to $24 from $17 at Barclays
1M ago
Pacira BioSciences Reports Record Revenue Amid Strategic Growth
PremiumCompany AnnouncementsPacira BioSciences Reports Record Revenue Amid Strategic Growth
1M ago
Pacira reports Q4 non-GAAP EPS 96c, consensus 83c
Premium
The Fly
Pacira reports Q4 non-GAAP EPS 96c, consensus 83c
1M ago
Pacira sees FY25 revenue $725M-765M, consensus $747.55M
Premium
The Fly
Pacira sees FY25 revenue $725M-765M, consensus $747.55M
1M ago
Pacira announces Board Chair Hastings retired, Brege to succeed
PremiumThe FlyPacira announces Board Chair Hastings retired, Brege to succeed
2M ago
Pacira upgraded to Hold from Sell at Truist
Premium
The Fly
Pacira upgraded to Hold from Sell at Truist
2M ago
Pacira upgraded to Hold from Sell at Truist
Premium
The Fly
Pacira upgraded to Hold from Sell at Truist
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100